CorMedix (CRMD) Receivables - Other (2010 - 2024)

CorMedix (CRMD) posted Receivables - Other of $500000.0 for Q2 2024, up 1.24% sequentially from $493855.0 in Q4 2011.

CorMedix (CRMD) Receivables - Other (2010 - 2024) Analysis & Trends

CorMedix has reported Receivables - Other for 3 years, with the latest figure at $500000.0 in Q2 2024.

Quarterly Receivables - Other changed N/A year-over-year to $500000.0 in Q2 2024, while the trailing twelve-month figure through Jun 2024 was $500000.0 (changed N/A YoY) and the FY2011 annual result came in at $493855.0, up 75.8% from the prior year.
Receivables - Other climbed to $500000.0 in Q2 2024 per CRMD's latest filing, from $493855.0 in the prior quarter.
Over five years, Receivables - Other peaked at $500000.0 in Q2 2024 and troughed at $500000.0 in Q2 2024.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Vertex Pharmaceuticals	139.13 Bn	131.28 Bn	2.84 Bn
2	Regeneron Pharmaceuticals	85.77 Bn	77.77 Bn	3.93 Bn
3	Argenx Se	64.64 Bn	59.46 Bn	1.37 Bn
4	Moderna	58.29 Bn	53.16 Bn	52.00 Mn
5	BeOne Medicines	41.92 Bn	36.82 Bn	1.53 Bn
6	Alnylam Pharmaceuticals	31.58 Bn	28.28 Bn	992.69 Mn
7	BioNTech SE	28.12 Bn	9.73 Bn	668.28 Mn
8	Insmed	27.39 Bn	26.22 Bn	358.27 Mn
9	Royalty Pharma	27.27 Bn	26.43 Bn	-
10	CorMedix	645.20 Mn	388.51 Mn	77.13 Mn

Download Data